» Authors » Carol Babij

Carol Babij

Explore the profile of Carol Babij including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 117
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Liu L, Lee M, Kim J, Whittington D, Bregman H, Hua Z, et al.
Bioorg Med Chem . 2016 Apr; 24(10):2215-34. PMID: 27085672
One of the challenges for targeting B-Raf(V600E) with small molecule inhibitors had been achieving adequate selectivity over the wild-type protein B-Raf(WT), as inhibition of the latter has been associated with...
3.
Babij C, Zhang Y, Kurzeja R, Munzli A, Shehabeldin A, Fernando M, et al.
Cancer Res . 2011 Jul; 71(17):5818-26. PMID: 21742770
Despite the prevalence of KRAS mutations in human cancers, there remain no targeted therapies for treatment. The serine-threonine kinase STK33 has been proposed to be required for the survival of...
4.
Carnahan J, Beltran P, Babij C, Le Q, Rose M, Vonderfecht S, et al.
Mol Cancer Ther . 2010 Jul; 9(8):2399-410. PMID: 20663930
Raf inhibitors are under clinical investigation, specifically in patients with tumor types harboring frequent activating mutations in B-Raf. Here, we show that cell lines and tumors harboring mutant B-Raf were...
5.
Smith A, DeMorin F, Paras N, Huang Q, Petkus J, Doherty E, et al.
J Med Chem . 2009 Sep; 52(20):6189-92. PMID: 19764794
The discovery and optimization of a novel series of aminoisoquinolines as potent, selective, and efficacious inhibitors of the mutant B-Raf pathway is presented. The N-linked pyridylpyrimidine benzamide 2 was identified...